PRTA · Prothena Corp Plc
United States · RS rating 42 · As of 2026-11-03
| Price | 8.21 USD |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 42 / 54 / 59 / 34 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 19 / 49 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +41.2% |
| Sales growth Q/Q | -99.1% |
| Distance from 52-week high | +28.7% |
| Market cap (USD) | $577.6M |